Pierre Lozeron
Inserm(FR)Université Paris Cité(FR)Sorbonne Paris Cité(FR)Hôpital Lariboisière(FR)Optimisation Thérapeutique en Neuropsychopharmacologie(FR)
Publications by Year
Research Areas
Peripheral Neuropathies and Disorders, Amyloidosis: Diagnosis, Treatment, Outcomes, Hereditary Neurological Disorders, Peripheral Nerve Disorders, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis(2013)955 cited
- → Tafamidis for transthyretin familial amyloid polyneuropathy(2012)785 cited
- → Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy(2009)188 cited
- → Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin(2012)187 cited
- → Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France(2015)180 cited
- → Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy(2013)127 cited